Your browser doesn't support javascript.
loading
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.
Cheng, Wei; Li, Hao-Long; Xi, Shao-Yan; Zhang, Xiao-Feng; Zhu, Yun; Mo, Yan-Xuan; Li, Mei-Mei; Kong, Fan-En; Zhu, Wen-Jie; Chen, Xiao-Gang; Cui, Hui-Qing; Cao, Zhi-Ming; Gong, Yuan-Feng; Tang, Yun-Qiang; Zhang, Yan; Guan, Xin-Yuan; Ma, Ning-Fang; Liu, Ming.
Afiliação
  • Cheng W; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Li HL; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Xi SY; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Zhang XF; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Zhu Y; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Le Xing; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Mo YX; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Li MM; Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Kong FE; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Zhu WJ; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Chen XG; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Cui HQ; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Cao ZM; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Gong YF; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Tang YQ; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Zhang Y; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Guan XY; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
  • Ma NF; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, 511436, China.
  • Liu M; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, 510095, China.
Nat Commun ; 12(1): 7142, 2021 12 08.
Article em En | MEDLINE | ID: mdl-34880251

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Fator 1 de Diferenciação de Crescimento / Plasticidade Celular / Imunoterapia Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Fator 1 de Diferenciação de Crescimento / Plasticidade Celular / Imunoterapia Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article